scholarly journals Addition of amifostine to the CHOP regimen in elderly patients with aggressive non-Hodgkin lymphoma: a phase II trial showing reduction in toxicity without altering long-term survival

2012 ◽  
Vol 5 (3) ◽  
pp. 152-157 ◽  
Author(s):  
Henry L. Gómez ◽  
César Samanéz ◽  
Frank Campana ◽  
Silvia P. Neciosup ◽  
Luis Vera ◽  
...  
Keyword(s):  
Elderly Patients ◽  
Hodgkin Lymphoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Chop Regimen ◽  
Term Survival ◽  
Long Term Survival ◽  
Non Hodgkin Lymphoma

scholarly journals Randomized phase II trial of CODE or AP after chemoradiotherapy for LD-SCLC: Long-term survival and toxicity analysis

2019 ◽  
Vol 30 ◽  
pp. v712
Author(s):  
Sekine ◽  
H. Harada ◽  
N. Yamamoto ◽  
M. Wakabayashi ◽  
H. Murakami ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Trial ◽  
Term Survival ◽  
Long Term Survival ◽  
Randomized Phase Ii ◽  
Toxicity Analysis
Sign in / Sign up

Export Citation Format

Share Document